|
FBXO7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.66422431391311E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.03940189788432E-11 |
| Normal-vs-Stage2 |
9.21719999991133E-07 |
| Normal-vs-Stage3 |
2.21267448807794E-13 |
| Normal-vs-Stage4 |
3.06454861487282E-12 |
| Stage1-vs-Stage2 |
7.154400E-01 |
| Stage1-vs-Stage3 |
1.808950E-01 |
| Stage1-vs-Stage4 |
2.163700E-02 |
| Stage2-vs-Stage3 |
6.400600E-01 |
| Stage2-vs-Stage4 |
1.842590E-01 |
| Stage3-vs-Stage4 |
2.002400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.0458300891969E-13 |
| Normal-vs-AfricanAmerican |
1.20050000051997E-07 |
| Normal-vs-Asian |
4.80750000031449E-07 |
| Caucasian-vs-AfricanAmerican |
3.976400E-01 |
| Caucasian-vs-Asian |
2.382200E-01 |
| AfricanAmerican-vs-Asian |
1.299640E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.8238971684973E-11 |
| Normal-vs-Female |
1.69053659959673E-12 |
| Male-vs-Female |
9.076800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.2049995163087E-10 |
| Normal-vs-Age(41-60Yrs) |
1.85420012677184E-10 |
| Normal-vs-Age(61-80Yrs) |
1.62481139653892E-12 |
| Normal-vs-Age(81-100Yrs) |
8.00010000000517E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.159800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.291870E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.333400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.843600E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.824200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.241600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.263580E-03 |
| Classical-VS-Follicular |
8.831500E-04 |
| Classical-VS-Other |
5.159000E-01 |
| Classical-VS-Normal |
6.11569683783841E-11 |
| Tall-VS-Follicular |
9.422400E-01 |
| Tall-VS-Other |
6.983200E-01 |
| Tall-VS-Normal |
1.90214510809028E-12 |
| Follicular-VS-Other |
6.693000E-01 |
| Follicular-VS-Normal |
1.84219306476052E-12 |
| Other-VS-Normal |
1.338220E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.26689769786026E-11 |
| Normal-vs-N1 |
2.70194977503024E-12 |
| N0-vs-N1 |
1.009190E-01 |
|
|
